药理治疗MASLD:当代治疗和未来的前景
1Department of Hypertension and Diabetology, Medical University of Gdansk, ul. Mariana Smoluchowskiego 17, 80-214 Gdańsk, Poland.
International journal of molecular sciences
|July 12, 2025
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 的新兴药物显示出有前途. 针对GLP-1,PPAR和FXR受体的治疗方法正在进步,为患有这种广泛的肝脏疾病的患者提供了希望.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 代谢疾病 代谢疾病
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD),以前称为NAFLD,是全球最常见的慢性肝病.
- MASLD与肥胖,2型糖尿病和代谢综合征密切相关,代表着一个重大的和日益增长的公共卫生挑战.
- 目前,尽管MASLD的患病率很高,并且有可能发生进展,但尚未批准针对MASLD的特定药理疗法.
研究的目的:
- 审查目前正在临床研究中的MASLD新兴药理疗法.
- 专注于最近在随机临床试验中评估的药物.
- 根据分子机制对试验药物进行分类,并总结它们的疗效,安全性和开发状态.
主要方法:
- 通过对 ClinicalTrials.gov 数据库进行系统搜索,截至2025年4月.
- 确定的研究重点是针对MASLD的药理学药物.
- 关于药物机制,疗效,安全性和临床试验阶段的数据被提取和合成.
主要成果:
- 调查中的关键药物类别包括GLP-1受体激活剂,PPAR激活剂,FXR激活剂以及ACC和DGAT的抑制剂.
- 这些疗法在改善肝硬化症,肝酶水平和代谢参数方面表现出令人鼓舞的结果.
- 几种有前途的药物正处于临床开发的先进阶段.
结论:
- 新兴的药理疗法显示出管理MASLD的巨大潜力.
- 针对特定代谢途径的药物为临床实践提供了一个有希望的未来.
- 预计在不久的将来,进一步的研究和临床试验将导致对MASLD的批准疗法.
更多相关视频
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
593
06:52Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
Published on: September 29, 2014
53.9K
相关概念视频
01:28Drug Therapy
105
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
105
01:23Antidepressant Drugs: MAOIs and Other Agents
372
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
372
01:29Inflammatory Bowel Disease IV: Pharmacological Management
198
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
198
01:22Alzheimer's Disease: Treatment
263
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
263
01:26Psychosis: Goals of Pharmacotherapy
212
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
212
01:29Cardiomyopathy V: Interprofessional Care
37
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
37